Switching from Eltrombopag to Hetrombopag in Patients with Primary Immune Thrombocytopenia (ITP): Post-Hoc Analysis of a Multicenter, Randomized Phase III Trial
机构:[1]Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Hematol, Wuhan, Peoples R China华中科技大学同济医学院附属协和医院[2]Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Tianjin, Peoples R China[3]Sichuan Univ, West China Hosp, Chengdu, Peoples R China四川大学华西医院[4]Sichuan Univ, West China Hosp, Inst Hematol, Dept Hematol, Chengdu, Peoples R China四川大学华西医院[5]Zhengzhou Univ, Affiliated Canc Hosp, Zhengzhou, Peoples R China河南省肿瘤医院[6]Guangzhou Med Univ, Affiliated Hosp 2, Dept Hematol, Guangzhou, Peoples R China[7]Air Force Med Univ, Affiliated Hosp 1, Xian, Peoples R China[8]Guangxi Med Univ, Affiliated Hosp 1, Nanning, Peoples R China[9]Nanchang Univ, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China[10]Shanxi Med Univ, Affiliated Hosp 2, Dept Hematol, Taiyuan, Peoples R China[11]Fujian Inst Hematol, Union Hosp, Dept Hematol, Fuzhou, Peoples R China[12]Shandong Univ, Qilu Hosp, Dept Hematol, Jinan, Peoples R China[13]Baoji Cent Hosp, Baoji, Peoples R China[14]Air Force Med Univ, Affiliated Hosp 2, Xian, Peoples R China[15]Shaanxi Prov Peoples Hosp, Dept Hematol, Xian, Peoples R China陕西省人民医院[16]Soochow Univ, Affiliated Hosp 1, Suzhou, Peoples R China[17]Changzhi Med Coll, Heping Hosp, Changzhi, Peoples R China[18]Zhejiang Univ, Affiliated Hosp 1, Coll Med, Hangzhou, Peoples R China浙江大学医学院附属第一医院[19]Hebei Med Univ, Hosp 2, Shijiazhuang, Hebei, Peoples R China[20]Kunming Med Univ, Hematol Res Ctr Yunnan Prov, Affiliated Hosp 1, Dept Hematol, Kunming, Yunnan, Peoples R China昆明医科大学附属第一医院[21]Wuxi Peoples Hosp, Wuxi, Jiangsu, Peoples R China[22]Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China[23]Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China[24]Jilin Univ, China Japan Union Hosp, Changchun, Peoples R China吉林大学中日联谊医院[25]Jiangsu Hengrui Pharmaceut Co Ltd, Shanghai, Peoples R China
第一作者机构:[1]Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Hematol, Wuhan, Peoples R China
推荐引用方式(GB/T 7714):
Yu Hu,Yang Renchi,Ting Niu,et al.Switching from Eltrombopag to Hetrombopag in Patients with Primary Immune Thrombocytopenia (ITP): Post-Hoc Analysis of a Multicenter, Randomized Phase III Trial[J].BLOOD.2022,140:5543-5545.doi:10.1182/blood-2022-162945.
APA:
Yu Hu,Yang, Renchi,Ting Niu,Heng Mei,Liu Xiaofan...&Zou, Jianjun.(2022).Switching from Eltrombopag to Hetrombopag in Patients with Primary Immune Thrombocytopenia (ITP): Post-Hoc Analysis of a Multicenter, Randomized Phase III Trial.BLOOD,140,
MLA:
Yu Hu,et al."Switching from Eltrombopag to Hetrombopag in Patients with Primary Immune Thrombocytopenia (ITP): Post-Hoc Analysis of a Multicenter, Randomized Phase III Trial".BLOOD 140.(2022):5543-5545